← Leaderboards
John Carroll
University Of Colorado Denver
$381,494
Attributed
$381,494
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$381,494 · 1
By mechanism
M01$381,494 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Robert Turner Schooley$73,100,957
- Andrew P Fontenot$19,585,312
- Dana Sue Hardin$2,621,431
- Robert H Eckel$10,073,870
- Donald Ym Leung$75,548,590
Others in their field
Top investigators on “Cardiovascular Agents”
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,877,416
- Judith S. Currier · University Of California Los Angeles$143,754,724
- David M Nathan · Massachusetts Institute Of Technology$120,538,040
- John M Lachin · George Washington University$118,921,924
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Paul M. Ridker · Brigham And Women'S Hospital$55,589,862
Research focus
Cardiovascular AgentsCardiovascular Disorder ChemotherapyCardiovascular PharmacologyClinical ResearchHeart FailureHuman SubjectHuman Therapy EvaluationIntravenous AdministrationPharmacokinetics
Grant awards (5)
SINGLE INTRAVENOUS DOSE OF MCC-135 FOR HEART FAILURE$190,747
M01 · FY2002 · RR
SINGLE INTRAVENOUS DOSE OF MCC-135 FOR HEART FAILURE$190,747
M01 · FY2001 · RR
SINGLE INTRAVENOUS DOSE OF MCC-135 FOR HEART FAILURE$0
M01 · FY2001 · RR
SINGLE INTRAVENOUS DOSE OF MCC-135 FOR HEART FAILURE$0
M01 · FY2000 · RR
SINGLE INTRAVENOUS DOSE OF MCC-135 FOR HEART FAILURE$0
M01 · FY2000 · RR